RESPIVERT LTD innovation strategy

Patent filings in countries

#	Country	Total Patents
#1	United States	63
#2	United Kingdom	41
#3	EPO (European Patent Office)	39
#4	WIPO (World Intellectual Property Organization)	34
#5	Australia	24
#6	China	24
#7	Republic of Korea	19
#8	Canada	18
#9	Mexico	17
#10	Brazil	15
#11	EAPO (Eurasian Patent Organization)	14
#12	Chile	10
#13	Taiwan	10
#14	Costa Rica	9
#15	Hong Kong	9
#16	Nicaragua	9
#17	Peru	9
#18	South Africa	9
#19	Colombia	8
#20	Ecuador	8
#21	New Zealand	8
#22	Singapore	8
#23	Argentina	7
#24	Israel	7
#25	Japan	6
#26	Uruguay	5
#27	Malaysia	4
#28	Philippines	4
#29	Ukraine	4
#30	Guatemala	3
#31	Jordan	3
#32	Serbia	3
#33	Honduras	2
#34	India	2
#35	Montenegro	2
#36	Hungary	1
#37	Slovenia	1

#	Technology
#1	Therapeutic chemical compounds
#2	Heterocyclic compounds
#3	Medical preparations
#4	Organic chemistry methods
#5	Special acyclic compounds
#6	Acyclic or carbocyclic compounds
#7	Unspecified technologies
#8	Climate change adaptation technologies
#9	Sugars
#10	Analysing materials

#	Name	Total Patents
#1	Ito Kazuhiro	171
#2	King-Underwood John	170
#3	Onions Stuart Thomas	157
#4	Murray Peter John	128
#5	Charron Catherine Elisabeth	110
#6	Williams Jonathan Gareth	90
#7	Rapeport William Garth	77
#8	Fyfe Matthew Colin Thor	75
#9	Strong Peter	74
#10	Copmans Alex Herman	67

Publication	Filing date	Title
CN109071505A	2017-04-06	Kinase inhibitor
CN109153666A	2017-03-08	Indole derivatives and its purposes as kinases inhibitor
KR20180128390A	2016-12-23	Indolinone compounds and their use in the treatment of fibrotic diseases
WO2016051186A1	2015-10-01	N-phenyl-3-quinazolin-6-yl-benzamide derivatives as p38 kinase inhibitors
KR20170057445A	2015-10-01	Diaryl urea derivative as p38 kinase inhibitors
GB201512737D0	2015-07-20	Assay
MX2016010571A	2015-02-13	Pyrazolyl-ureas as kinase inhibitors.
CN106029651A	2014-12-19	Urea derivatives useful as kinase inhibitors
GB201417346D0	2014-10-01	New compounds
GB201413015D0	2014-07-23	Assay
WO2014162122A1	2014-04-01	Kinase inhibitor
US2014274980A1	2014-03-14	Phosphoinositide 3-kinase inhibitors
JO3279B1	2014-03-13	2-((4-amino-3-(3-fluoro-5-hydroxyphenyl)-1h-pyrazolo[3,4-d]pyrimidin-1-yl)methyl)-3-(2-(trifluoromethyl)benzyl)quinazolin-4(3h)-one derivatives and their use as phosphoinositide 3-kinase inhibitors
EP2970190A1	2014-03-13	Kinase inhibitors
GB201402647D0	2014-02-14	New compounds
GB201322678D0	2013-12-20	New compounds
GB201322684D0	2013-12-20	New compounds
GB201322672D0	2013-12-20	New compounds
GB201322681D0	2013-12-20	New compounds
US2015329523A1	2013-11-15	Kinase inhibitors